Enhancements    

R16: CHARACTERIZATION OF NOVEL PYRAZOLE COMPOUNDS WITH POTENT ANTI-CANCER ACTIVITY

R16: CHARACTERIZATION OF NOVEL PYRAZOLE COMPOUNDS WITH POTENT ANTI-CANCER ACTIVITY
PI: Renato Aguilera
Sponsor: NIH - NATIONAL CANCER INSTITUTE
Biological Sciences
Amount awarded: $605,440

This funding supports research on anti-cancer compounds that have potential to kill human cancers and, thus, reduce cancer health disparities.

Posting date: Wed, 05/17/2023

Award start date: Mon, 05/01/2023
Award end date: Wed, 03/31/2027